Clenergen Corp. offers strategic clean energy generation and sustainable fuel supply projects to address the requirement for renewable and sustainable supplies of power. The company announced today that it had signed a memorandum of agreement with Growmore Biotech to undertake commercial trials of Clenergen’s tree species and bamboo on 900 acres of land the company has under agreement in India, Ghana, Guyana and the Philippines.
Currently, the company has scheduled 22,000 acres under 49-year lease agreements in these countries. This acreage is projected to yield over 880,000 tons of biomass per year by 2014 and provide fuel supply for 110 megawatts per hour of biomass power plant capacity.
Clenergen intends to produce up to 200,000 saplings per week from tissue culture. The saplings will be shipped in quarantine-approved containers with each sapling being identical in yield, as well as being asexual and non-invasive. The trials will assist in confirming the appropriate pesticides and fertilizer regime for each region identified for the trial. The trials are expected to last six months prior to commencing full-scale plantations in each region.
Commenting on the agreement, the CEO of Clenergen Mark Quinn said, “The commercial trials of our energy crops in these regions marks a cornerstone for the sustainable and profitable use of marginalized land. The biomass feedstock produced will provide a valuable source of fuel for generating renewable power.”
For more information on Clenergen, please visit clenergen.com.
Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net
Disclosure: no positions